Viewing Study NCT04434092


Ignite Creation Date: 2025-12-24 @ 3:20 PM
Ignite Modification Date: 2026-05-17 @ 12:48 PM
Study NCT ID: NCT04434092
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-10
First Post: 2020-06-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors
Sponsor: Hoffmann-La Roche
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Paroxysmal Nocturnal Hemoglobinuria View
Keywords: